Skip Navigation
About
Team
News
Portfolio
Contact
news
In the Media
2020-02-13 // Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19
Go to Article
2020-01-14 // Gates vets at Adjuvant back Codagenix’s software-driven approach to recoding RSV, fly oncolytic viruses and more
Go to Article
2020-01-13 // Codagenix raises $20 million for a new flu vaccine and other therapies
Go to Article
2019-11-21 // AN2 Therapeutics Raises $12M in Series A Funding
Go to Article
2019-11-21 // AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences
Go to Article
2019-09-23 // Financing Global Health
Go to Article
Posts pagination
Previous
1
…
6
7
8
Next
Adjuvant seeks out the most innovative life sciences companies in the world.
See our Portfolio